Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.
HealthTree Podcast for AML — June 23, 2022
Join us on June 29th at 2 pm EST to hear from Dr. Jane Liesveld from the University of Rochester about FLT3 inhibitor drugs available and in development.
AML News—May 31, 2022
Servier Pharmaceuticals anncounces that a new treatment combination utilizing their drug Tibsovo (ivosidenib) was FDA approved this past week.
HealthTree Podcast for AML—May 26, 2022
Listen to the full recording of our conversation with Dr. Joseph Jurcic, an AML expert, about a new immunotherapy drug in development called magrolimab.
AML Clinical Trials—May 25, 2022
This update provides the first clear signal that MRD responses following DCP-001 vaccination translate into relevant survival benefits for AML patients.
Life with AML—May 23, 2022
Acute myeloid leukemia is an emotional battle. Perspective is key to maintaining mental and emotional health.